Accrual to Clinical Trials (ACT)
The Accrual to Clinical Trials (ACT) Network is a real-time platform allowing researchers to explore and validate feasibility for clinical studies across the NCATS Clinical and Translational Science Award (CTSA) consortium, from their desktops. ACT helps researchers plan and complete clinical studies, and is IRB-approved. To access the ACT platform, researchers at Columbia University must contact our Clinical Data Navigator.
ACT was developed collaboratively by members of NCATS’ Clinical and Translational Science Award (CTSA) consortium, with funding from the NIH National Center for Advancing Translational Sciences.
This service is available to all researchers and clinical trialists at Columbia University.
When to Request This Service
This service should be requested at least two months prior to any grant or protocol submission deadlines.
There is no cost for this service.
Cite it, Submit it, Share it!
If your research has benefited from one or more Irving Institute resources, please remember to: